MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Acrivon Therapeutics (ACRV) Ownership - Who owns Acrivon Therapeutics?
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.79M
P/E Ratio
N/A
Total Cash
187.45M
Projected Growth
N/A
Total Debt
4.01M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACRV
Capitalization
42.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
187M
Total Cash/Share
5.98
Total Debt
4.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
197M
P/B Ratio
0.24
Cash Flow
N/A
Earnings
-2.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
12.75
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-84.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-42.09
Shares Held By Institutions
152M
Shares Outstanding - Current
31.4M
Total Liabilities
17.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-76.910
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com